| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |